GSTP1 and cancer: Another covalent inhibitor, GS-ESF, targets the G-site of GSTP1(Shishido et al. 2017), while NBDHEX also acts covalently to modify the enzyme’s active site and trigger apoptosis in cancer cells (Tentori et al. 2011; De Luca et al. 2014).